Mangrove Partners’s Larimar Therapeutics LRMR Stock Holding History

Quarter	Market Value	Status	Shares	Shares Change %	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$2.23M	Hold	770,233	–	–	0.24%	52
2025 Q1	$1.66M	Hold	770,233	–	–	0.18%	63
2024 Q4	$2.98M	Sell	770,233 -85,582	-10%	-$331K	0.33%	50
2024 Q3	$5.61M	Hold	855,815	–	–	0.48%	56
2024 Q2	$6.2M	Hold	855,815	–	–	0.48%	61
2024 Q1	$6.5M	Buy	855,815 +50,000	+6%	+$380K	0.45%	65
2023 Q4	$3.67M	Hold	805,815	–	–	0.25%	93
2023 Q3	$3.18M	Hold	805,815	–	–	0.24%	105
2023 Q2	$2.52M	Hold	805,815	–	–	0.17%	133
2023 Q1	$3.65M	Sell	805,815 -486,997	-38%	-$2.21M	0.24%	136
2022 Q4	$5.34M	Hold	1,292,812	–	–	0.3%	85
2022 Q3	$4.14M	Buy	1,292,812 +425,000	+49%	+$1.36M	0.24%	174
2022 Q2	$1.7M	Hold	867,812	–	–	0.08%	341
2022 Q1	$3.52M	Buy	867,812 +627,859	+262%	+$2.54M	0.19%	204
2021 Q4	$2.59M	Buy	+239,953	New	+$2.59M	0.15%	207
2020 Q4	–	Sell	-146,142	Closed	-$2.22M	–	112
2020 Q3	$2.22M	Hold	146,142	–	–	0.28%	42
2020 Q2	$1.88M	Sell	146,142 -1,616,684	-92%	-$20.8M	0.46%	33
2020 Q1	$1.36M	Sell	1,762,826 -13,818	-0.8%	-$10.6K	0.19%	38
2019 Q4	$1.97M	Hold	1,776,644	–	–	0.29%	36
2019 Q3	$1.31M	Hold	1,776,644	–	–	0.16%	68
2019 Q2	$2.11M	Buy	1,776,644 +567,320	+47%	+$675K	0.24%	52
2019 Q1	$3.31M	Buy	1,209,324 +471,695	+64%	+$1.29M	0.44%	41
2018 Q4	$3.65M	Hold	737,629	–	–	0.49%	35
2018 Q3	$8.62M	Hold	737,629	–	–	0.54%	19
2018 Q2	$7.55M	Buy	737,629 +150,000	+26%	+$1.53M	0.49%	20
2018 Q1	$4.38M	Hold	587,629	–	–	0.29%	26
2017 Q4	$2.72M	Buy	587,629 +27,644	+5%	+$128K	0.37%	26
2017 Q3	$1.97M	Buy	+559,985	New	+$1.97M	0.34%	27